1. Home
  2. VTRS vs SBAC Comparison

VTRS vs SBAC Comparison

Compare VTRS & SBAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viatris Inc.

VTRS

Viatris Inc.

HOLD

Current Price

$16.97

Market Cap

18.7B

Sector

Health Care

ML Signal

HOLD

SBAC

SBA Communications Corporation

HOLD

Current Price

$184.70

Market Cap

19.4B

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTRS
SBAC
Founded
1961
1989
Country
United States
United States
Employees
30000
N/A
Industry
Medicinal Chemicals and Botanical Products
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
18.7B
19.4B
IPO Year
2019
1999

Fundamental Metrics

Financial Performance
Metric
VTRS
SBAC
Price
$16.97
$184.70
Analyst Decision
Buy
Buy
Analyst Count
4
17
Target Price
$13.50
$233.12
AVG Volume (30 Days)
9.4M
1.0M
Earning Date
05-07-2026
04-29-2026
Dividend Yield
3.21%
2.31%
EPS Growth
N/A
41.21
EPS
0.05
3.61
Revenue
$14,299,900,000.00
$2,815,139,000.00
Revenue This Year
$4.41
$2.80
Revenue Next Year
$1.96
$2.76
P/E Ratio
$336.20
$51.52
Revenue Growth
N/A
5.06
52 Week Low
$9.43
$162.41
52 Week High
$18.39
$224.46

Technical Indicators

Market Signals
Indicator
VTRS
SBAC
Relative Strength Index (RSI) 53.24 51.11
Support Level $15.95 $178.85
Resistance Level $17.17 $189.74
Average True Range (ATR) 0.35 3.55
MACD 0.04 0.55
Stochastic Oscillator 75.11 55.25

Price Performance

Historical Comparison
VTRS
SBAC

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

About SBAC SBA Communications Corporation

SBA Communications owns a portfolio of about 46,000 wireless towers throughout North America, South America, and Africa. It leases space on its towers to wireless service providers, who install equipment to support their wireless networks. The company has a very concentrated customer base, with most revenue in each market generated by the top three or four mobile carriers. It owns more than 17,000 towers in the US, which account for about 70% of leasing revenue. Internationally, SBA's largest markets are Brazil and Guatemala, where it owns roughly 12,000 and 5,000 towers, respectively. SBA operates as a real estate investment trust.

Share on Social Networks: